Physician

Natan Ryan Shaoulian, M.D.

According to 2025 Medicare claims, Natan Shaoulian, M.D. (NPI: 1114926433) practices neurology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is NERVE MD, INC. (NPI: 1841427507; TIN: 943473930) and primary practice location at 90230-4801.

Shaoulian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 220 traditional Medicare patients, billed 180,230 HCPCS/CPT codes, and received $6,847,630 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,150 prescription claims across 153 beneficiaries totaling $254,429 in drug costs, led by Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50). 2015 DME data shows 27 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,447,464 to $6,847,630. In contrast, Part D prescription costs have fallen sharply in recent years, from $1,193,127 to $254,429. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.9M$7.8M2015 Medicare payment: $1,447,464 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,651,855 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,045,670 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,096,529 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,516,275 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,349,917 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $5,183,096 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $7,784,367 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $7,356,310 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $6,847,630 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201526044,962$1,447,464
201628750,655$1,651,855
201733874,098$2,045,670
201828266,347$2,096,529
201924974,653$2,516,275
2020212103,313$3,349,917
2021201153,015$5,183,096
2022218158,912$7,784,367
2023250164,242$7,356,310
2024220180,230$6,847,630

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$791K$1.6M2015 Drug cost: $1,193,127 (USD; Tot_Drug_Cst)2016 Drug cost: $1,581,019 (USD; Tot_Drug_Cst)2017 Drug cost: $1,502,283 (USD; Tot_Drug_Cst)2018 Drug cost: $1,157,120 (USD; Tot_Drug_Cst)2019 Drug cost: $869,184 (USD; Tot_Drug_Cst)2020 Drug cost: $975,012 (USD; Tot_Drug_Cst)2021 Drug cost: $478,354 (USD; Tot_Drug_Cst)2022 Drug cost: $318,213 (USD; Tot_Drug_Cst)2023 Drug cost: $302,148 (USD; Tot_Drug_Cst)2024 Drug cost: $254,429 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152132,276$1,193,127
20162112,414$1,581,019
20172062,074$1,502,283
20181771,623$1,157,120
20191741,437$869,184
20201321,301$975,012
20211361,140$478,354
20221321,106$318,213
20231571,219$302,148
20241531,150$254,429

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$10K$20K2015 Medicare payment: $20,418 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R27$20,418
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more7373$186
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more82122$152
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less591,168$57
J1459Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg57168,270$38
96366Infusion into a vein for therapy, prevention, or diagnosis, each additional hour591,253$18

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5011308$211,203
Rasagiline MesylateRasagiline Mesylate723,060$16,581
Memantine Hcl ErMemantine Hcl1134,474$8,568
Carbidopa-LevodopaCarbidopa/Levodopa1063,727$2,392
Carbidopa-Levodopa ErCarbidopa/Levodopa411,410$1,357

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Natan Ryan Shaoulian, M.D.?

Tedicare shows public-source Medicare data for Natan Ryan Shaoulian, M.D. (NPI 1114926433), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Natan Ryan Shaoulian, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Natan Ryan Shaoulian, M.D.?

Natan Ryan Shaoulian, M.D. is linked to NERVE MD, INC. (billing NPI 1841427507) in the available physician profile data.

Does Natan Ryan Shaoulian, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.